StockNews.com Initiates Coverage on CASI Pharmaceuticals (NASDAQ:CASI)
StockNews.com began coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Get Free Report) in a research note issued on Tuesday. The brokerage set a “hold” rating on the biotechnology company’s stock. Separately, HC Wainwright dropped their price target on CASI Pharmaceuticals from $6.00 to $4.00 and set a “buy” rating for the company in a […]
StockNews.com began coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Get Free Report) in a research note issued on Tuesday. The brokerage set a “hold” rating on the biotechnology company’s stock. Separately, HC Wainwright dropped their price target on CASI Pharmaceuticals from $6.00 to $4.00 and set a “buy” rating for the company in a […]
